Virginia lawmakers are taking a bold step to regulate the sale of kratom and enhance consumer protection with the introduction of VA SB164. Proposed on November 19, 2024, this bill aims to address growing concerns over the safety of kratom products and the transparency of consumer transactions.

At the heart of VA SB164 is a provision that prohibits the sale of kratom products to anyone under 21 years old. Additionally, sellers must ensure that all kratom products are clearly labeled with ingredient lists and include a health warning stating, "This product may be harmful to your health, has not been evaluated by the FDA, and is not intended to diagnose, treat, cure, or prevent any disease." This move comes amid increasing scrutiny of kratom, a substance derived from the Mitragyna speciosa plant, which has been linked to health risks and addiction.

The bill also tackles consumer rights by mandating full disclosure of costs associated with goods and services, including any hidden fees, before a sale is finalized. Furthermore, it requires transparency regarding the use of artificial intelligence in creating media that depicts real individuals, ensuring consumers are aware of the technology behind the products they purchase.

While the bill has garnered support for its consumer protection measures, it has also sparked debates about the implications for businesses and the kratom industry. Critics argue that stringent regulations could stifle sales and innovation, while proponents emphasize the need for safety and informed consumer choices.

As Virginia prepares to discuss VA SB164 further, the bill's potential impact on public health and consumer rights remains a focal point. If passed, it could set a precedent for how states regulate emerging substances and technologies, reflecting a growing trend towards greater accountability in consumer markets. The legislative journey of this bill will be closely watched, as its outcomes could resonate beyond Virginia's borders.